Home
›
BridgeBio Oncology Therapeutics, Inc.
› 8-K Sep 8, 2026
BridgeBio Oncology Therapeutics, Inc. (BBOT): 8-K filed Sep 8, 2026
Form type
8-K
Filing date
Sep 8, 2026
Accession number
0001193125-26-385225
Filer
BridgeBio Oncology Therapeutics, Inc.
(CIK 1869105)